2022 R&D Spend: Novo Nordisk spent 24.05 billion DKK ($3.40 billion USD) on R&D in 2022, a 35.31 percent increase from the 17.77 billion DKK ($2.83 billion USD) the company spent on R&D in 2021
Higher time in range with combined therapy In a second presentation, Chantal Mathieu, MD, PhD, professor of medicine and chair of endocrinology at the University Hospital Gasthuisberg Leuven in Belgium, presented CGM data from the trial
Patients should contact their healthcare provider if they experience severe or persistent side effects, are unable to tolerate the medication, or have concerns about their response to treatment
How to Get Rid of GLP-1 Nausea: Expert Tips for Relief GLP-1 medications like semaglutide (Ozempic and Wegovy) 1 and tirzepatide (Zepbound and Mounjaro) 2 have become go-to treatments for individuals managing type 2 diabetes and those working towards weight loss
Low quality products can increase the risk of side effects